T. Rowe Price logo

T. Rowe Price

North America, Maryland, United States, Baltimore

Description

T. Rowe Price is a globally recognized independent investment management firm, headquartered in Baltimore, Maryland, with a long history primarily focused on public equities and fixed income. While not a traditional early-stage venture capital firm, the company has established a substantial presence in the private markets, particularly through its growth equity strategies. They act as a significant crossover investor, deploying capital into late-stage, high-growth technology companies that are often on the cusp of an initial public offering (IPO) or other major liquidity events. Their investment approach is characterized by deep fundamental research and a long-term perspective, aiming to partner with companies that have proven business models, strong management teams, and significant market opportunities.

The firm's private investments typically target companies that have already achieved considerable scale and revenue, distinguishing them from seed or Series A investors. T. Rowe Price often participates in, and frequently leads, large funding rounds for established private technology firms. For instance, they led a $250 million Series E round for Databricks in 2019, demonstrating their capacity to deploy substantial capital into promising ventures. Their portfolio includes numerous high-profile tech unicorns such as Snowflake, Airbnb, DoorDash, and Stripe, where they have often been key participants in multi-hundred-million-dollar funding rounds.

Given their strategic focus on growth equity, the typical "first check" from T. Rowe Price is significantly larger than those from early-stage venture capitalists. Their initial investments in a company generally range from approximately $25 million to upwards of $250 million, depending on the company's stage, capital needs, and the overall size of the funding round. This substantial check size reflects their preference for taking meaningful stakes in mature private companies, leveraging their extensive capital base, which manages over $1.4 trillion in assets globally as of December 31, 2023. They are a crucial source of capital for companies seeking to scale rapidly and prepare for public market entry.

Investor Profile

T. Rowe Price has backed more than 346 startups, with 18 new investments in the last 12 months alone. The firm has led 89 rounds, about 26% of its total and boasts 141 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series D, Series B rounds (top funding stages).
  • Majority of deals are located in United States, India, United Kingdom.
  • Strong thematic focus on Biotechnology, Health Care, Medical.
  • Led 4 rounds in the past year.
  • Typical check size: $25M – $250M.

Stage Focus

  • Series C (17%)
  • Series D (16%)
  • Series B (11%)
  • Series E (10%)
  • Series Unknown (9%)
  • Series F (9%)
  • Private Equity (8%)
  • Post Ipo Equity (6%)
  • Series G (5%)
  • Series A (3%)

Country Focus

  • United States (92%)
  • India (2%)
  • United Kingdom (1%)
  • Australia (1%)
  • Canada (1%)
  • Germany (1%)
  • France (1%)
  • China (1%)
  • Colombia (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Software
  • Therapeutics
  • Artificial Intelligence (Ai)
  • Pharmaceutical
  • Life Science
  • Saas
  • Information Technology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does T. Rowe Price frequently co-invest with?

Baillie Gifford
Europe, Edinburgh, City of, United Kingdom, Edinburgh
Co-Investments: 28
Wellington Management
North America, Massachusetts, United States, Boston
Co-Investments: 30
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 24
Dragoneer Investment Group
North America, California, United States, San Francisco
Co-Investments: 24
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 27
BlackRock
North America, New York, United States, New York
Co-Investments: 33
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 26
Andreessen Horowitz
North America, California, United States, Menlo Park
Co-Investments: 31
Tiger Global Management
North America, New York, United States, New York
Co-Investments: 34
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 96

Which angels does T. Rowe Price often collaborate with?

MV
North America, Washington, United States, Seattle
Shared Deals: 2
Shared Deals: 1
ES
North America, California, United States, Mountain View
Shared Deals: 3
JL
North America, United States
Shared Deals: 1
AG
North America, New Jersey, United States, New Brunswick
Shared Deals: 1
SS
North America, California, United States, Los Angeles
Shared Deals: 2
BN
North America, Massachusetts, United States, Boston
Shared Deals: 1
OV
North America, California, United States, San Francisco
Shared Deals: 1
David J. Adelman
North America, Pennsylvania, United States, Philadelphia
Shared Deals: 2
SP
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by T. Rowe Price?

Cellares

South San Francisco, California, United States

Cellares is an Integrated Development and Manufacturing Organization dedicated to the automated, large-scale production of cell therapies.

BiotechnologyLife ScienceManufacturingMedicalTherapeutics
Series DJan 28, 2026
Amount Raised: $257,000,000
Cyclic Materials

Kingston, Ontario, Canada

Cyclic Materials is a cleantech company that develops a circular supply chain for rare earth elements and critical metals.

CleanTechIndustrialManufacturingRecyclingSustainability
Series CJan 23, 2026
Amount Raised: $75,000,000
ClickHouse

Mountain View, California, United States

ClickHouse provides an open-source database system for real-time analytical reporting.

AnalyticsArtificial Intelligence (AI)Big DataDatabaseSoftware
Series DJan 16, 2026
Amount Raised: $400,000,000
Mirador Therapeutics

San Diego, California, United States

Mirador Therapeutics develops precision medicines for immune-mediated diseases.

BiotechnologyHealth CareMedicalTherapeutics
Series BJan 12, 2026
Amount Raised: $250,000,000
Alamar Biosciences

Fremont, California, United States

Powering precision proteomics to enable to the earliest detection of disease.

BiotechnologyHealth CareLife ScienceMedical
Convertible NoteJan 11, 2026
Amount Raised: $50,000,000
Hadrian

Hawthorne, California, United States

Hadrian builds AI-powered automated factories that manufacture precision parts for defense, aerospace, and space industries.

AerospaceArtificial Intelligence (AI)Machinery ManufacturingManufacturingSupply Chain Management
Series UnknownJan 9, 2026
Amount Raised: $131,307,594
Parabilis Medicines

Cambridge, Massachusetts, United States

Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.

BiopharmaBiotechnologyHealth CareLife ScienceMedicalPharmaceuticalPrecision Medicine
Series FJan 8, 2026
Amount Raised: $305,000,000
Emirates NBD

Dubai, Dubai, United Arab Emirates

Emirates NBD is a retail banking franchise that offers personal banking, private banking, and corporate banking services.

BankingFinanceFinancial Services
Post Ipo DebtJan 7, 2026
Amount Raised: $1,000,000,000
Databricks

San Francisco, California, United States

Databricks is a data and AI platform that unifies data engineering, analytics, and machine learning on a lakehouse architecture.

AnalyticsArtificial Intelligence (AI)Data StorageInformation TechnologyMachine Learning
Series UnknownDec 16, 2025
Amount Raised: $4,000,000,000
K2 Space

Torrance, California, United States

K2 Space develops high-power satellite platforms for orbital missions, using vertically integrated hardware and manufacturing processes.

AerospaceMachinery ManufacturingManufacturingSpace Travel
Series CDec 11, 2025
Amount Raised: $250,000,000

Find More Investors Like T. Rowe Price

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides